Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. - Wikidata - wikimedia - TriplyDB

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.

http://www.wikidata.org/entity/Q32072017

about

Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1 Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment.Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.Functional alpha-1B adrenergic receptors on human epicardial coronary artery endothelial cells A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation Liver regeneration following partial hepatectomy is improved by enhancing the HGF/Met axis and Akt and Erk pathways after low-power laser irradiation in rats.Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway.STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers.Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms.Hepatocyte growth factor as potential cardiovascular therapy.Targeting cancer by binding iron: Dissecting cellular signaling pathways Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.Proline-rich tyrosine kinase 2 via enhancing signal transducer and activator of transcription 3-dependent cJun expression mediates retinal neovascularization The shadow of death on the MET tyrosine kinase receptor.Differential inhibitor of Gbetagamma signaling to AKT and ERK derived from phosducin-like protein: effect on sphingosine 1-phosphate-induced endothelial cell migration and in vitro angiogenesis Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion Hepatocyte growth factor in lung repair and pulmonary fibrosis.Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis.Therapeutic potential of hepatocyte growth factor against cerebral ischemia (Review).2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β Activation.Role of protein kinase C isoforms in the regulation of interleukin-13-induced 15-lipoxygenase gene expression in human monocytes.HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies.Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3 RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer.The anti-angiogenic activities of glycyrrhizic acid in tumor progression.Recent progress in therapeutic angiogenesis.Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3.Brain-derived neurotrophic factor stimulates bone/cementum-related protein gene expression in cementoblasts.Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling.Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor The chemokine KC regulates HGF-stimulated epithelial cell morphogenesis.Modulation of immune response by RAGE and TLR4 signalling in PBMCs of diabetic and non-diabetic patients.Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca(2+)- and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells.

P2860

Q24630178-750BF238-0F47-41CA-8C4B-A48AA8A51735 Q24683896-E1B0DD2A-9E50-4426-A08A-76C85F0F6791 Q24811689-D06D1D5B-3983-4B04-9F7C-B9FEBE09E704 Q24812420-B112119C-3FF4-4127-9FB0-721C6E21FA20 Q28216726-F0D31525-CEBD-4EA5-931B-DF03C8B3EE41 Q33328109-98E7C067-6015-4895-B2BB-6FBE10416D6B Q33913784-D28A42C7-0FD0-4C16-99D5-25E17C660FDD Q33921803-2581661E-4230-416B-BF8E-9162854E45B9 Q33970473-00F03144-2994-4C09-A44B-E0D797BB6C28 Q34068447-DCC2EF90-B6F6-4FCA-AF54-AA65BA098D0C Q34347226-1961FBBA-F08B-495A-8D47-306216099F91 Q34426051-9DE18206-E10A-4D05-928D-8F8A28BF92FE Q34555238-3E2D5F1A-8309-4CAE-8ABA-EFD55D876C01 Q35047460-A7B1A27B-05E1-437E-ADD2-0F86CCE5F81E Q35747457-92CEB67A-211B-4226-AE51-E8F1BB7AD2B3 Q36001216-530776C8-F76D-46C9-9C9C-403CC6AE7898 Q36124924-4B13BA9E-ACCA-43E9-88FA-1B5A5B0D89CE Q36326247-D4A356E2-C16E-4B6F-B17F-EF8779F6B1C5 Q36482246-9997F06F-41EA-499B-AF58-8B444B3F7DF2 Q36925591-726EFFE2-E768-43E4-B83A-5B3187B2A8D0 Q36961606-6971AF43-307D-4BCD-AFA1-381EE281FABF Q37258536-C49B1774-043A-4BBD-B1DC-797849827302 Q37340100-4DEB7F04-9148-4D6C-9083-CD4584388E20 Q37729853-C4BFEC02-9526-4902-980B-12872E8BFD05 Q38088776-EF192845-92DC-4FA6-A199-2D0B45D5BE44 Q38312563-22D5FFD2-6207-4D0E-A414-23F81FEA2337 Q38324927-A0AB028D-0762-45D2-983B-FBD5D6CF4A7D Q38345132-1D35D0D3-C0B4-474F-A648-7BA931BFB43E Q38397298-9D2C11C5-1A92-47E8-A68C-AB071AB206B0 Q38726100-D085A61C-C819-4E2E-8799-16D208AE9952 Q38953542-D272967A-96BB-4ECF-BD4A-2A13AE20FAEE Q39296184-FF971CFE-5A05-4599-B092-B7FFB9CE8C0A Q39526666-E9CDB2D5-68C9-48A5-ABBA-D02023F160A4 Q39753333-0B2D2A9A-0748-4236-85E6-84381B566B99 Q39994919-F16532B7-75FD-41A8-AA80-4A443AFFFA33 Q40148697-CD8374E2-00C5-4356-B10D-06ABDE6CD6B2 Q40461761-AA5B9ADC-CB15-4549-80AE-456B55772219 Q40619606-0A9C67AA-66AF-4BB2-BCA6-7404694B5740 Q41738633-88046862-4340-48AF-AFBC-3E62BC637EFB Q41903087-6DC8C48F-0321-4457-A949-20004FA6A382

P2860

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.

http://www.wikidata.org/entity/Q32072017

description

2001 nî lūn-bûn

@nan

2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Mitogenic and antiapoptotic ac ...... and AKT in endothelial cells.

@ast

Mitogenic and antiapoptotic ac ...... and AKT in endothelial cells.

@en

type

label

Mitogenic and antiapoptotic ac ...... and AKT in endothelial cells.

@ast

Mitogenic and antiapoptotic ac ...... and AKT in endothelial cells.

@en

prefLabel

Mitogenic and antiapoptotic ac ...... and AKT in endothelial cells.

@ast

Mitogenic and antiapoptotic ac ...... and AKT in endothelial cells.

@en

P1433

Q32072017-9BB584B1-6295-4E9D-896F-45DA6464C3E7

P1476

Q32072017-F834BD59-8793-4BBB-83B2-FC6AE9F06526

P2093

Q32072017-046AB6A9-0C2A-42CF-B32F-7918E03A71E3

Q32072017-34B3DF87-5947-430D-AA60-A404462EBD9E

Q32072017-5963815D-F25D-4430-9D50-5A13224151E1

Q32072017-940F90C9-90EF-4141-895D-92F06CF16953

Q32072017-9CE1110D-2076-45F5-956E-F7F7FCC45CE1

Q32072017-D5F49616-F0EA-4DA5-8063-BD843887BCFA

Q32072017-E6B7275B-BE43-47C8-901C-A2342269E55E

Q32072017-EBA3DD05-9B1A-4A03-9A09-DE090C212D84

Q32072017-F8857A7A-1CF5-41AE-BB40-0ED949C29FB1

P304

Q32072017-683E8072-2E3A-43AB-BD40-29A83C3C3935

P31

Q32072017-8997A42F-9637-4034-AEC0-3099F7B29CCE

P356

Q32072017-7FECF90E-FAF4-46A0-BDBC-64C8316C8C45

P407

Q32072017-E7BECC6C-B802-4472-B6F7-8CD63759980F

P433

Q32072017-E9476FD0-13AE-4C52-BA5C-D09899AF86E1

P478

Q32072017-507A0C7D-5897-4703-9E43-2F067BBDB5E5

P50

Q32072017-BE9D5990-AB2D-40DB-8597-C30859D06EE4

P577

Q32072017-26E0168A-E0F1-4078-A3B4-88A47B9BDE9D

P5875

Q32072017-E883258D-291D-4184-843C-BE749A8C34F2

P698

Q32072017-CE96D906-44DF-4946-AF4B-14A4EC8D3D78

P921

Q32072017-DC6361B4-82C4-4C76-8F4A-036624F43AAB

P356

01.HYP.37.2.581

P1433

P1476

Mitogenic and antiapoptotic ac ...... and AKT in endothelial cells.

@en

P2093

K Matsumoto

http://www.w3.org/2001/XMLSchema#string

K Yamamoto

http://www.w3.org/2001/XMLSchema#string

M Aoki

http://www.w3.org/2001/XMLSchema#string

M Horiuchi

http://www.w3.org/2001/XMLSchema#string

R Morishita

http://www.w3.org/2001/XMLSchema#string

T Nakamura

http://www.w3.org/2001/XMLSchema#string

T Ogihara

http://www.w3.org/2001/XMLSchema#string

Y Kaneda

http://www.w3.org/2001/XMLSchema#string

Y Taniyama

http://www.w3.org/2001/XMLSchema#string

P304

581-586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.HYP.37.2.581

http://www.w3.org/2001/XMLSchema#string

P407

P433

2 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Hironori Nakagami

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12101974

http://www.w3.org/2001/XMLSchema#string

P698

11230338

http://www.w3.org/2001/XMLSchema#string

P921